Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy

Microbes and Infection

Volumn 16, Issue 7, 2014, Pages 571-580

  Agarwal, Pooja ^a   Khan, Shaheb R ^a   Verma, Subash C ^a   Beg, Muheeb ^a   Singh, Kavita ^a   Mitra, Kalyan ^a,b   Gaikwad, Anil N ^a,b   Akhtar, Md Sohail ^a,b   Krishnan, Manju Y ^a,b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

Adipocytes; Mouse adipose depots; Mycobacterium tuberculosis; Persistence

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; ADIPOCYTOKINE; CYTOKINE; FAT DROPLET; TUBERCULOSTATIC AGENT;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; DRUG EFFECT; IMMUNOCOMPETENCE; IMMUNOMODULATION; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; TUBERCULOSIS;

BACILLI (CLASS); BACTERIA (MICROORGANISMS); MURINAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; ANTITUBERCULAR AGENTS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; LIPID DROPLETS; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84903720092     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.04.006     Document Type: Article

References (34)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999, 282:677-686.
2. Styblo K., Meijer J. Increase in the annual level of tuberculosis in a country with a low occurrence: measurement of the increase expecting to see if the existing program of mass radiographic examinations was interrupted. Bull Int Union Tuberc 1980, 55:3-8.
3. Parrish N.M., Dick J.D., Bishai W.R. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 1998, 6:107-112.
4. Selwyn P.A., Hartel D., Wasserman W., Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 1989, 79:1358-1362.
5. Gomez J.E., McKinney J.D. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 2004, 84:29-44.
6. Lee J., Gong S., Lee B., Lee S., Kim N. Miliary tuberculosis occurred after immunosuppressive drug in PNH patient with completely cured tuberculosis; a case report. Ann Clin Microbiol Antimicrob 2012, 11:12.
7. Ehlers S. Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis. Infection 2009, 37:87-95.
8. Boshoff H.I., Barry C.E. Tuberculosis - metabolism and respiration in the absence of growth. Nat Rev Microbiol 2005, 3:70-80.
9. Hadlich E., Galperim B., Rizzon C.F. Esophageal ulcers caused by reactivation of ganglionary tuberculosis: a case report. Braz J Infect Dis 2007, 11:293-296.
10. Gori A., Fabroni C., Prignano F., Lotti T. Unusual presentation of tuberculosis in an infliximab-treated patient-which is the correct TB screening before starting a biologic?. Dermatol Ther 2010, 23(Suppl. 1):S1-S3.
11. Pednekar M., Chandra A.B., Chandra P.A. Disseminated tuberculosis secondary to adalimumab. Am J Ther 2012, 19:e139-e140.
12. Hernández-Pando R., Jeyanathan M., Mengistu G., Aguilar D., Orozco H., Harboe M., et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000, 356:2133-2138.
13. Neyrolles O., Hernández-Pando R., Pietri-Rouxel F., Fornès P., Tailleux L., Barrios Payán J.A., et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence?. PLoS One 2006, 1:e43.
14. Barrios-Payán J., Saqui-Salces M., Jeyanathan M., Alcántara-Vazquez A., Castañon-Arreola M., Rook G., et al. Extrapulmonary locations of Mycobacterium tuberculosis DNA during latent infection. J Infect Dis 2012, 206:1194-1205.
15. Das B., Kashino S.S., Pulu I., Kalita D., Swami V., Yeger H., et al. CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis. Sci Transl Med 2013, 5:170ra113.
16. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
17. Pond C.M. Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids 2005, 73:17-30.
18. Ogawa R., Mizuno H., Watanabe A., Migita M., Hyakusoku H., Shimada T. Adipogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice-including relationship of sex differences. Biochem Biophys Res Commun 2004, 319:511-517.
19. Sugihara H., Yonemitsu N., Miyabara S., Yun K. Primary cultures of unilocular fat cells: characteristics of growth in vitro and changes in differentiation properties. Differentiation 1986, 31:42-49.
20. Christensen H., Garton N.J., Horobin R.W., Minnikin D.E., Barer M.R. Lipid domains of mycobacteria studied with fluorescent molecular probes. Mol Microbiol 1999, 31:1561-1572.
21. Grosset J., Truffot-Pernot C., Lacroix C., Ji B. Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice. Antimicrob Agents Chemother 1992, 36:548-551.
22. Shin S.J., Han J.H., Manning E.J., Collins M.T. Rapid and reliable method for quantification of Mycobacterium paratuberculosis by use of the BACTEC MGIT 960 system. J Clin Microbiol 2007, 45:1941-1948.
23. van Embden J.D., Cave M.D., Crawford J.T., Dale J.W., Eisenach K.D., Gicquel B., et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993, 31:406-409.
24. Erol A. Visceral adipose tissue specific persistence of Mycobacterium tuberculosis may be reason for the metabolic syndrome. Med Hypotheses 2008, 71:222-228.
25. Toda S., Uchihashi K., Aoki S., Sonoda E., Yamasaki F., Piao M., et al. Adipose tissue-organotypic culture system as a promising model for studying adipose tissue biology and regeneration. Organogenesis 2009, 5:50-56.
26. Peyron P., Vaubourgeix J., Poquet Y., Levillain F., Botanch C., Bardou F., et al. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 2008, 4:e1000204.
27. Kim J.S., Ryu M.J., Byun E.H., Kim W.S., Whang J., Min K.N., et al. Differential immune response of adipocytes to virulent and attenuated Mycobacterium tuberculosis. Microbes Infect 2011, 13:1242-1251.
28. Caire-Brändli I., Papadopoulos A., Malaga W., Marais D., Canaan S., Thilo L., et al. Reversible lipid accumulation and associated division arrest of Mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis. Infect Immun 2014, 82:476-490.
29. Lin Y., Lee H., Berg A.H., Lisanti M.P., Shapiro L., Scherer P.E. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 2000, 275:24255-24263.
30. Tasaka S., Hasegawa N., Nishimura T., Yamasawa W., Kamata H., Shinoda H., et al. Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Respiration 2010, 79:383-387.
31. Keicho N., Matsushita I., Tanaka T., Shimbo T., Hang N.T., Sakurada S., et al. Circulating levels of adiponectin, leptin, fetuin-A and retinol-binding protein in patients with tuberculosis: markers of metabolism and inflammation. PLoS One 2012, 7:e38703.
32. Chackerian A.A., Alt J.M., Perera T.V., Dascher C.C., Behar S.M. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 2002, 70:4501-4509.
33. Jones B.E., Oo M.M., Taikwel E.K., Qian D., Kumar A., Maslow E.R., et al. CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis 1997, 24:988-991.
34. Dhillon J., Fourie P.B., Mitchison D.A. Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media. J Antimicrob Chemother 2014, 69:437-440.